198 related articles for article (PubMed ID: 8022815)
1. Altered natural killer cell repertoire in Tap-1 mutant mice.
Ljunggren HG; Van Kaer L; Ploegh HL; Tonegawa S
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6520-4. PubMed ID: 8022815
[TBL] [Abstract][Full Text] [Related]
2. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.
Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG
J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379
[TBL] [Abstract][Full Text] [Related]
3. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
Falk CS; Steinle A; Schendel DJ
J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
[TBL] [Abstract][Full Text] [Related]
4. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
[TBL] [Abstract][Full Text] [Related]
5. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.
Wolpert EZ; Petersson M; Chambers BJ; Sandberg JK; Kiessling R; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11496-501. PubMed ID: 9326638
[TBL] [Abstract][Full Text] [Related]
6. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
Zimmer J; Donato L; Hanau D; Cazenave JP; Tongio MM; Moretta A; de la Salle H
J Exp Med; 1998 Jan; 187(1):117-22. PubMed ID: 9419217
[TBL] [Abstract][Full Text] [Related]
7. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1.
Petersson M; Charo J; Salazar-Onfray F; Noffz G; Mohaupt M; Qin Z; Klein G; Blankenstein T; Kiessling R
J Immunol; 1998 Sep; 161(5):2099-105. PubMed ID: 9725200
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene.
Franksson L; George E; Powis S; Butcher G; Howard J; Kärre K
J Exp Med; 1993 Jan; 177(1):201-5. PubMed ID: 8418201
[TBL] [Abstract][Full Text] [Related]
9. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice.
Dorfman JR; Zerrahn J; Coles MC; Raulet DH
J Immunol; 1997 Dec; 159(11):5219-25. PubMed ID: 9548460
[TBL] [Abstract][Full Text] [Related]
10. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
[TBL] [Abstract][Full Text] [Related]
11. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.
Höglund P; Ohlén C; Carbone E; Franksson L; Ljunggren HG; Latour A; Koller B; Kärre K
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10332-6. PubMed ID: 1946452
[TBL] [Abstract][Full Text] [Related]
12. Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.
Ayalon O; Hughes EA; Cresswell P; Lee J; O'Donnell L; Pardi R; Bender JR
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2435-40. PubMed ID: 9482903
[TBL] [Abstract][Full Text] [Related]
13. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells.
Correa I; Raulet DH
Immunity; 1995 Jan; 2(1):61-71. PubMed ID: 7541307
[TBL] [Abstract][Full Text] [Related]
14. Target-cell sensitivity to natural killer-cell lysis is determined by the expression of a novel antigen in conjunction with major histocompatibility complex class-I molecules.
Harris DT; Jaso-Friedmann L; Evans DL
Scand J Immunol; 1994 Jan; 39(1):73-8. PubMed ID: 8290895
[TBL] [Abstract][Full Text] [Related]
15. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.
Cretney E; Degli-Esposti MA; Densley EH; Farrell HE; Davis-Poynter NJ; Smyth MJ
J Exp Med; 1999 Aug; 190(3):435-44. PubMed ID: 10430631
[TBL] [Abstract][Full Text] [Related]
16. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand.
Orihuela M; Margulies DH; Yokoyama WM
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11792-7. PubMed ID: 8876216
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processing.
Ossevoort MA; Sijts AJ; van Veen KJ; Momburg F; Hämmerling GJ; Seelig A; Butcher GW; Howard JC; Kast WM; Melief CJ
Eur J Immunol; 1993 Dec; 23(12):3082-8. PubMed ID: 8258321
[TBL] [Abstract][Full Text] [Related]
18. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression.
Zimmer J; Donato L; Hanau D; Cazenave JP; Moretta A; Tongio MM; de la Salle H
Eur J Immunol; 1999 Apr; 29(4):1286-91. PubMed ID: 10229096
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
20. Effect of interleukin-2 on generation of natural killer cells: role of major histocompatibility complex class I in B6 and TAP-1-/- mice.
Delfino DV; Di Marco B; Marchetti C; Bartoli A; Ayroldi E; Bruscoli S; Agostini M; Spinicelli S; Zollo O; Migliorati G
J Chemother; 2000 Apr; 12(2):160-6. PubMed ID: 10789556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
